Cite
MLA Citation
Sivagurunathan Sutharsan et al.. “Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.” Lancet, vol. 10, no. 3, 2022, pp. 267–277. http://access.bl.uk/ark:/81055/vdc_100152621933.0x00000a